Bio Time, Inc.

Bio Time, Inc.
Bio Time, Inc.

BioTime is a biotechnology company focused on the emerging field of regenerative medicine. Our core technologies center on pluripotent stem cells that are capable of becoming all of the cell types in the human body. Products made from these stem cells are being developed by our subsidiaries, each of which concentrates on different medical specialties, including: neuroscience, oncology, orthopedics, and blood and vascular diseases. BioTime’s commercial strategy targets near-term yet strategic commercial opportunities such as: Renevia (a product currently in clinical trials in Europe to facilitate cell transplantation our current line of research products); ReGlyde and Premvia for tendon and dermatological applications; PureStem cell lines and associated ESpan culture media, GMP-capable human embryonic stem cell lines; PanC-Dx (a novel blood-based cancer screen); and the LifeMap Database Suite. Cellular therapeutics in development include: OpRegen (hESC-derived RPE cells for the treatment of macular degeneration); OPC1 ( hESC-derived oligodendrocyte progenitors for spinal cord injury); and VAC1 (a dendritic cell-based vaccine for cancer based on the telomerase antigen).
1301 Harbor Bay Parkway, Suite 100
Alameda, CA 94502
510-521-3390- ex311

Send Message to listing owner

Bio Time, Inc.

Our Newest Members

Visit Us!

Alameda Chamber of Commerce
2215-A South Shore Center
Alameda,CA 94501
(510) 522-0414